Next Article in Journal
The Initial Response to COVID-19 Disruptions for Older People with HIV in Ukraine
Previous Article in Journal
Association between Polypharmacy and Cardiovascular Autonomic Function among Elderly Patients in an Urban Municipality Area of Kolkata, India: A Record-Based Cross-Sectional Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Socioeconomic Inequalities in the Prevalence of Non-Communicable Diseases among Older Adults in India

by
Bikash Khura
1,†,
Parimala Mohanty
2,†,
Lipilekha Patnaik
2,*,
Keerti Bhusan Pradhan
3,
Jagdish Khubchandani
4 and
Bijaya Kumar Padhi
5,*
1
International Institute for Population Sciences, Mumbai 400088, India
2
Department of Community Medicine, Institute of Medical Sciences & SUM Hospital, Siksha ‘O’ Anusandhan (Deemed to be University), Bhubaneswar 751030, India
3
Department of Public Health Management, Chitkara University, Rajpura 140401, India
4
Department of Public Health, New Mexico State University, Las Cruces, NM 88003, USA
5
Department of Community Medicine and School of Public Health, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Geriatrics 2022, 7(6), 137; https://doi.org/10.3390/geriatrics7060137
Submission received: 22 October 2022 / Revised: 25 November 2022 / Accepted: 28 November 2022 / Published: 5 December 2022

Abstract

:
Understanding socioeconomic inequalities in non-communicable disease prevalence and preventive care usage can help design effective action plans for health equality programs among India’s aging population. Hypertension (HTN) and diabetes mellitus (DM) are frequently used as model non-communicable diseases for research and policy purposes as these two are the most prevalent NCDs in India and are the leading causes of mortality. For this investigation, data on 31,464 older persons (aged 60 years and above) who took part in the Longitudinal Ageing Survey of India (LASI: 2017–2018) were analyzed. The concentration index was used to assess socioeconomic inequality whereas relative inequalities indices were used to compare HTN, DM, and preventive care usage between the different groups of individuals based on socioeconomic status. The study reveals that wealthy older adults in India had a higher frequency of HTN and DM than the poor elderly. Significant differences in the usage of preventive care, such as blood pressure/blood glucose monitoring, were found among people with HTN or DM. Furthermore, economic position, education, type of work, and residential status were identified as important factors for monitoring inequalities in access to preventive care for HTN and DM. Disparities in non-communicable diseases can be both a cause and an effect of inequality across social strata in India.

1. Introduction

The age distribution of the population has changed dramatically across the globe. Declining mortality and advancements in medical and scientific knowledge are the drivers of prolonged life expectancy [1]. By 2050, it is estimated that more than 200 million people over the age of 60 would be added to the global population [2]. Specifically, the population of low and middle-income nations, such as India, is rapidly aging. For example, in India, the proportion of older adults has increased from 5% of the total population in 1951 to 8.6% in 2011 and is expected to reach 20% of the overall population by 2050 [3]. Population aging is a global concern regarding labor markets, health system requirements, economics, and social welfare. As people begin to age, they are more likely to develop various chronic diseases. Not only do older people have to deal with a plethora of chronic diseases, but there are also differences in health status between sub-age groups of older people, with some groups faring better than others based on a variety of socioeconomic factors. This makes access to health care even more unjust and unequal [4]. Despite progress in improving access to health care, disparities based on sex, caste, wealth, education, and residence prevail [5]. To achieve health equity, policymakers must measure inequalities in health care, especially as it relates to wealth and income inequalities [6].
Studies show that non-communicable diseases (NCDs) that differently manifest between the wealthy and the deprived are major predictors of premature mortality and differences in life expectancy among older people [7,8]. According to the Global Burden of Diseases (GBD) report, cardiovascular diseases, chronic lung illness, and DM are the leading causes of death globally [1,9,10]. In India, NCDs claim the lives of nearly 6 million people [11]. The GBD collaborators of India observed that primarily, cardiovascular diseases contributed to more than a third (34.3%) of India’s mortality burden [12] and diabetes mellitus accounts for 2.5% of the total burden of mortality [13]. In addition, the prevalence of NCDs continues to escalate in India with major public health implications, predominantly in older adults.
In terms of disease burden, NCDs account for 62 percent of DALYs jeopardizing long-term growth and affecting individual productivity in India [14]. NCDs account for 40% of hospital admissions and 35% of outpatient admissions, causing loss of productive years of life. This, in turn, creates further income inequalities by loss of income and wealth in households where the poor are disproportionately affected [15]. Furthermore, in nearly half of the NCD cases, the majority of the cost is shifted to individuals and families (i.e., out-of-pocket payments) [16].
It is well established in the scientific literature that socioeconomic status is the most important factor influencing the distribution of chronic diseases in and within communities [17,18]. Globally, the relationship between the occurrence of NCDs and economic status varies widely with pronounced regional differences [19]. The socioeconomic pattern of inequality in the prevalence of NCD differs from one country to another and within nations depending on prevalent health and social policies [20]. For example, studies from India itself have found an association between the prevalence of NCDs such as hypertension(HTN) and diabetes mellitus (DM) and the socioeconomic position of individuals [21,22,23,24].
In addition to NCDs, there are differences based on SES in the utilization of preventive therapies and adherence to medications for NCDs [25,26,27]. Diabetic patients must be monitored for and advised on blood glucose checks, adherence to hypoglycemic medicines, and dietary habits to regulate blood glucose and avoid complications [28]. Despite the relatively modest expenditure for preventative care for NCDs in most nations, people from economically underprivileged sections do not often utilize or are offered preventive care and are as a consequence, more likely to experience premature mortality due to chronic diseases than their wealthier counterparts [20].
India, with its diverse socio-cultural, economic, and geographic makeup has recognized and responded, by implementing multi-sectoral NCD prevention initiatives to tackle health inequalities [29,30]. For example, policy and attention from governance, such as the implementation of national policies in line with the SDG paradigm [16] have remained the mainstay in addressing the NCDs. Specific initiatives from the government and community agencies have focused on factors such as prevention, education, treatment, and rehabilitative services to achieve the SDG goal of 3.4 (which suggests a reduction by a third in early deaths caused by NCDs by the year 2030 [31]. However, it has not been thoroughly explored whether chronic disease prevention techniques and initiatives were widely implemented and equitable in India. Very little information is available about socioeconomic inequality in the prevalence of NCDs, especially among older adults. So, such a study is much needed because NCDs (HTN and DM) vary among members of a given society and have a remarkable influence on the well-being of India’s aging population. Thus, the purpose of this study was to comprehensively and systematically examine socioeconomic inequality in the prevalence of NCDs and the use of preventive care among the aging population and also, to explore the role of other socioeconomic predictors in health inequalities for older Indian adults.

2. Materials and Methods

2.1. Data

The analysis is based on data collected from the 2017–2018 national survey of longitudinal aging in India (LASI), which focuses on the well-being, economy, and social elements of India’s aging population [32]. The International Institute for Population Sciences (IIPS) in Mumbai conducted the study in partnership with international collaboration [33]. The sample consists of 72,250 older citizens who are 45 years of age or older along with their spouses from across India except for Sikkim state. The final units of observation were chosen by LASI using a multistage stratified area probability cluster sampling design. In addition, the LASI 2017–2018 report provides details of the sampling frame and methodology [32]. This survey on aging provides empirical evidence on health, demographics, and, social determinants. The sizes of the LASI datasets that were finally included in our analyses are described in Figure 1.

2.2. Variable Description

In this study, the eligibility criteria of the study population was older adults aged 60 years and above. We used data from 31,464 people (15,098 older males and 16,366 older females). Further adults below 60 years were excluded from the analysis. The following key variables were considered for analysis.
Outcome variable: The presence of hypertension (HTN) and diabetes mellitus (DM) along with its preventive treatment (use of medicine) among older adults with HTN and DM. In this study, we used self-reported HTN and DM as model NCDs as they are the most common NCDs in India and the leading causes of mortality [24,34,35].
Self-reported HTN /DM (diagnosed by a physician) was used to determine the existence of HTN/DM by answering questions such as“Have you ever been diagnosed with hypertension?” along with “Have you ever been diagnosed with diabetes?”. All outcome variables were binary. The existence of HTN and/or DM was the first group of variables.
The second group of variables was: If they had HTN or DM, whether they took their medicine as prescribed by their doctor, and if their blood pressure or blood glucose had been checked. Only those who reported having HTN or DM were investigated further on their medication use.
Exposure variable: As suggested by previous studies [36], in this study, house consumption spending per equivalent adult was also used as a proxy indicator of economic status. Further economic status was used in regression analysis, i.e., monthly per capita consumption expenditure (mpce_quintile) was divided into quintiles: poorest (lowest 22%, n = 6484 MPCE), poorer (lower 22%, n = 6477), middle (middle 21%, n = 6416), richer (higher 19%, n = 6172) and richest (highest 16%, n = 5917).
Explanatory variables:
The explanatory variable was categorized as participants of the 60–69 years age group, 70–79 years age group, and 80+ years age group. Gender was a binary variable (i.e men and women). Religions were categorized into four groups first Hindu, second Muslim, third Christian, and the fourth group as Others. Similarly, caste groups were categorized as scheduled caste (SC), scheduled tribes (ST), other backward class (OBC), and the fourth group as Others.
The other variable was classified as educational attainment as ‘illiterate’, ‘Primary or below’, ‘Secondary’ and ‘college and above’. Employment status was taken as ‘Unemployed’ and ‘Employed’. Marital status was taken as ‘Married’ or ‘Single’.
A direct acyclic graph (DAG) was used to identify covariates that should be adjusted while developing the model. Figure 2 shows a simplified DAG to facilitate readability. Covariates and arrows that have no bearing on the analysis are excluded.

2.3. Statistical Analysis

For statistical analysis a descriptive, basic weighted point estimate, “relative inequality index” (“RII”), “economic-related concentration index” (‘C’), and “decomposition analysis” for ‘C’ were undertaken in the study. In previous studies, “RII” and “C” are commonly used to estimate health or healthcare inequalities [37,38]. All estimates were calculated using survey weights and taking the complex survey design into account. The missing data were excluded from the analysis. Analysis after the exclusion of cases with missing data did not change the estimates.
The RII index compares extremes, whereas the C index measures socioeconomic inequality across the entire socioeconomic spectrum. For both HTN and DM, analyses were conducted sequentially.

2.3.1. The “Relative Index of Inequality”

“RII” indicators are used to compare ailment prevalence rates between those with the most and least socioeconomic status positioned people.” It is mainly utilized in epidemiology and public health [37].
The predicted prevalence of disease ratio between the disadvantaged and wealthy groups can be read as “RII”. As a result, an RII value of more than 1 indicates a greater prevalence among the poorest members of society and the other way around.
As proposed in other studies, Poisson regressions, with robust error variance, were used between economic groups to estimate the prevalence rate ratio adjusted for confounders (i.e., ‘RII’), as the outcome was binary in this study [39]. The ‘RII’ were calculated in 2 stages: they were first corrected for age and sex and then secondly, they were adjusted for education, occupation, and other social and economic characteristics.

2.3.2. Concentration Index

‘C’ assesses disparities across the socioeconomic spectrum and accounts for socioeconomic inequalities in health conditions/preventive care [38]. The “C” index has a value ranging from −1 to 1, with 0 indicating a perfect equality condition. So, a +ve C indicates that health condition/ preventive care is to a greater extent concentrated in the wealthier population and the other way round.
The C is denoted in the formula as:
C = 2 μ cov y i r i
where y denotes the health/health care factor (in this case, the prevalence of HTN/DM and its preventive treatment), μ denotes the mean of the health and healthcare variable, and r i denotes individual fractional ranking from a stretch of 0 to 1 in the economic distribution of people.

2.3.3. “Decomposition Analysis” for “C”

The “C” can be divided into demographic and socioeconomic components, according to Wagstaff et al. The contribution to that component is determined by the product of the degree of economic inequality and the sensitivity of the outcome variable [40].
As the outcome variable is binary; hence, a probit regression model has been used to estimate the partial effect of each predictor variable. However, the findings are not interpreted to imply a causal relationship [41]. The outcome variable (y) is modeled using the following model.
y i = k β k x ki + ε i
Here “βk” denotes the number of partial effects. Each regressor dy/dx is assessed as the mean of the sample, and “ε “as the error term from the mathematical model. “xk” denotes a set ofpredictors.
The ‘concentration index C” (y) can be decomposed as follows:
C = β k x ¯ k μ C k + GC ε μ
Here “βk” depicts the k regressors’ partial effects (that is, predictor), as calculated in Equation (2).
Each regressor’s mean is x ¯ k and μ is taken as the mean value of the body condition/ preventive approach. “Ck” refers to the “regressor concentration index”, and “GCε” refers tothe “generalized concentration index of ε”.
Further inequality is represented as the residual component GC ε μ that the regressors don’t explain. The deterministic element k ( β k x ¯ k μ ) C k concentrates on two components. The two components are the health elasticity and (Ck), which is the degree of unequal distribution of distinct regressors throughout the economic spectrum in relation to regressor η k = β k x ¯ k μ .
Further, each regressor’s absolute contribution of each regressor was calculated (Qk = ηkCk). Each regressor can contribute in either a positive or a negative way.
According to Equation (1), even if a predictor variable has a large effect on the health condition/ preventive care factor, when the factor is uniformly distributed in the rich section and poor, the predictor variable may not have a significant contribution to inequality [as per Equation (3)].
Moreover, disparities in health condition/preventive care are related to demographic variables such as age, as well as socioeconomic variables and urban-rural indicators. To determine whether demographic characteristics are unavoidable for modification, policymakers can choose to focus on socioeconomic inequality [42]. The age and gender-adjusted “C” was computed in the study by removing the contributions of age and gender from the overall “C” using the decomposition results [42,43].
The sampling methods were adjusted using national-level (indiahhweight) sampling weights to establish that the findings accurately represent the Indian elderly section of the population. The STATA14.2′s Svyset function was used to create all models. Furthermore, the standard errors for each of the analytic models were adjusted for clustering at the family level [44].
Ethical approval: Necessary requisite ethical approval has been obtained from the International Institute for Population Sciences (IIPS) team involved in the data collection method.

3. Results

The data for the distribution of descriptive variables used in the study are shown in Table 1. HTN and DM were prevalent in 33% and 14% of the population, respectively. Among hypertensive older adults, 77% were taking medications. Similarly, among people suffering from diabetes, 82% were taking medications.
The prevalence of HTN and DM, as well as the proportion of people who receive a preventive care service (treatment seek) with that of the economic quintile, the RII, and the economically linked ‘C’, is seen in Table 2. The socioeconomic-related “C” measured disparities across the economic spectrum, whereas the “RII” measured differences between the poorest and highest economic sections. The prevalence ratios for HTN and DM were 0.18 (95% CI: 0.17–0.20) and 0.06 (95% CI: 0.05–0.06) when RIIs were adjusted for various socioeconomic characteristics. The “Cs” with +ve values indicate that HTN and DM are more common in economically advantaged groups (HTN: C = 0.13; 95% CI, 0.09–0.16; DM: C = 0.10; 95% CI, 0.06–0.14). The adjusted prevalence ratio for individuals with HTN and DM who used appropriate treatment to manage high blood pressure was 0.56 (95% CI 0.53–6.60), and the adjusted prevalence ratio for blood sugar was 0.69. (95 percent CI 0.60–0.74). Positive “Cs” indicates that the wealthy are favored in preventive care for HTN and DM patients.

The ‘Cs’ Have Been Decomposed

The results of “Cs” for HTN and DM, as well as patient preventative care, are presented in Table 3.
The appearance of HTN and DM among those with preventive care (including those taking medication) was significantly and positively related to economic status, as seen by the partial impact estimates. The partial effect estimates on the presence of HTN for the poorer was 0.035, for the middle was 0.054, for the richer was 0.083, and for the richest was 0.104 were significant. Respondents in higher socioeconomic levels were likely to have HTN or DM. Those with HTN or DM were more likely to practice more effective preventive care strategies. The level of education was significant for HTN prevalence and use of preventive care; however, the level of education for preventive care of DM was inconsistent. Employment status was significantly and negatively associated with the prevalence of HTN and DM and their prevention. Respondents with HTN or DM who lived in cities were more likely to take their medications as prescribed.
We presented a detailed decomposition of the HTN prevalence using the ‘employment’ variable. The “Employed” group contributed 0.003 to the overall C. Further, the percentage contribution (2.45%) is calculated by dividing the absolute contribution (0.003) by the HTN prevalence concentration index.
Economic status, employment, caste, and educational level were the four main contributors to inequalities in NCDs (i.e., based on the contributions of different socioeconomic factors to differences in the prevalence of HTN or DM). Furthermore, economic position, caste, education, urban-rural location, religion, marital status, and occupation all played key roles in disparities favoring wealthy older adults in the prevention of HTN or DM. Socioeconomic status was found to have a significant influence on the prevalence of HTN and DM, as well as disparities in preventative treatment favoring wealthy older adults in India. The contribution of economic status was determined by its significant influence on the prevalence of the disease condition and associated preventive care, as well as their unequal distribution.
Table 4 summarizes the impact of “Cs” and age, as well as adjusted for sex “Cs,” on the occurrence of HTN and DM, as well as preventative therapy. The age and sex group contributions were estimated by combining the contributions of the age plus sex dummy variables using similar approaches as the previous group.
Figure 3 shows the distribution of the concentration curve of the cumulative proportion of the presence of HTN and the use of HTN medicine use, against the cumulative percentage of wealth.
Figure 4 shows the distribution of the concentration curve for the cumulative proportion of the presence of DM and the use of DM medicine use, against the cumulative percentage of wealth, in India (LASI).
Table 4 indicates economic status as the most important sociological factor (41–47%), while other sociological factors were less important (2–16%). Total observed discrepancies were influenced less by age and sex. For the prevalence of HTN and DM, the age-sex-adjusted Cs were 0.135 and 0.10, respectively. Taking into account both gender and age, the wealthy still had a higher prevalence of HTN and DM than the impoverished. The adjusted ‘C’ for age and sex to use medications for HTN and DM were 0.102 and 0.093, respectively. Even when gender and age differences were taken into account, there remained substantial inequality favoring the wealthy in preventive treatment for people with HTN or DM.

4. Discussion

In this large, national, comprehensive, and first-of-its-kind study of older adults in India, we found socioeconomic variations in the occurrence of non-communicable diseases and their preventive management as well as quantified the role of predictive variables in these disparities. Wealthy older adults in India have a higher prevalence of HTN and DM than the poverty-stricken section. There was a clear inequality in preventive care, and the wealthy benefited from adequate medication use and blood pressure/glucose monitoring among people with HTN or DM. The inequality in the prevalence of HTN and DM, as well as preventive care, was primarily driven by socioeconomic factors, and unobserved associations were revealed using decomposition analysis. For example, the prevalence of HTN and DM is accumulated among wealthy older adults. These results are in agreement with the findings from different parts of India [23,24,43]. A large number of studies conducted in low- and middle-income nations have shown a significant association between economic gradients and health outcomes [44,45,46,47]. Some studies in India also show an inverse economic gradient [48,49]. However, such a pattern is mostly observed in high-income countries [50,51,52]. In our analysis, the most likely explanation is that older people of lower socioeconomic statuses were unable to receive or were not offered therapy for HTN and DM. Some studies have also shown that the association between socioeconomic status and the prevalence of HTN and DM may vary or even reverse over time, especially in economically developing countries [17,53]. Currently, higher socioeconomic classes in India are at higher risk of HTN and DM as a result of rapid economic growth and a westernized lifestyle [54,55,56].
Differences in social, cultural, economic, and healthcare systems contribute to the uneven distribution of NCDs [20]. As a result of socioeconomic gaps in the prevalence of HTN and DM, our analysis also provides insights into the prevalence of chronic diseases among India’s older population. Strengthening preventative care for older adults with HTN or DM reduces complications and increases the likelihood of survival and well-being. However, our findings suggest that among older people with HTN or DM, there are explicit differences in preventive treatment that benefit the wealthy segment of society. These results corroborate earlier research showing an association between lower SES levels is associated with worse health outcomes among patients with NCDs around the world [20,57]. Specifically, cost, access, and quality of care all vary by SES in countries such as India.
Our findings highlight several critical socioeconomic factors related to preventive care for older people with HTN or DM. In this study, those in the poorest, middle, and richest socioeconomic sections were more likely to experience NCD. Previous studies have found that economic position, education, work status, and urban-rural divide have all been identified as key socioeconomic factors related to the use of preventive care services [25,58]. People’s health-seeking attitudes are often influenced by a variety of sociocultural factors that are linked to their socioeconomic level. This can be critical in deciding whether or not to pursue an NCDs prevention strategy [59]. The widespread diabetes burden is becoming a public health problem in both developed world and developing countries, with researchers estimating that one out of every two elderlyis likely to be diabetic or prediabetic [60]. Furthermore, significant socioeconomic inequalities in hypertension exist in developing countries such as Kenya, which are mostly explained by metabolic risk factors (BMI), individual health behaviors, and socioeconomic factors [61]. Interestingly, in developed countries, socioeconomic status, particularly wealth, is a substantial independent predictor of incident hypertension [62]. However, the current study found that the older population had the greatest concerns, with economic position, caste, educational level, urban-rural residency, religion, marital status, and work status all playing important roles in disparities favoring the richest section of society in the prevention of HTN and DM. Likewise, another study conducted inIndia found that the highest SES regions had the highest prevalence of hypertension, whereas the lowest SES regions had the lowest. In general, the study reflected higher income was related to a higher prevalence of hypertension. On the contrary, there was no evidence that educational attainment altered the relationship between income and hypertension [63]. Furthermore, in this study, after controlling for age and gender, we observed that the wealthy were more likely than the poor to have HTN and DM.
The U.N Sustainable Development Goals have emphasized the importance of paying more attention to elements related to the impact of socioeconomic factors on health inequalities (e.g., education, participation in policymaking, employment, etc.). As a result, targeted efforts should be made to address the disparities in the burden of non-communicable diseases (NCDs) and their preventive care services among the older population (which vary by socioeconomic status, employment, caste, and level of education, as evidenced by the findings of the study). Income and social support, health education and awareness campaigns, programs mimicking universal health coverage schemes for the marginalized, creating a pipeline of community health workers focusing on geriatric care, and creating a culture of NCD prevention and management for the elderly in primary and community care systems would further help reduce the disparities.
There are certain potential limitations of our investigation. The converse interpretation is also plausible because the current study was a cross-sectional study design with no full analysis of the link between causal factors of the prevalence of HTN or DM and its preventive care services. Furthermore, data on health outcomes were obtained by self-reporting, which may have led to an overestimation of the association between socioeconomic status and the prevalence of non-communicable diseases, and the utilization of preventive care. However, the data were the best available for analyzing potential associations between socioeconomic status and NCDs among the older population. In addition, the survey employs a complex sampling technique to obtain a representative sample at a low cost. Furthermore, using “C” for binary health variables captures the extent of socioeconomic inequality over the full socioeconomic range rather than just the variable’s upper boundary. Finally, in questionnaire-based surveys, recall biases are unavoidable, particularly for health conditions that occurred months before the survey.
Despite these limitations, ours is the largest investigation of NCDs in elderly Indians and the disparities in disease burden and lack of preventive care utilization. In addition, our utilization of a nationwide large survey dataset helped identify key socioeconomic differences in preventive treatment for patients in older adults in India. Future studies should consider tracking changes in non-communicable disease prevalence and inequalities in its prevention, as well as evaluating the effectiveness of healthcare programs in lowering these inequalities. Unlike previous studies on NCDs, the study’s findings distinctly demonstrated how socioeconomic factors and NCDs-related factors are linked to inequality among older people. Given the high prevalence of NCDs among older people and the growing aging population, the findings of the research emphasize the importance of strengthening health care, preventive services, and social security programs that can help older persons avoid potential problems as they age. In general, improving the health of the older population would result in lower government spending on healthcare needs.

5. Conclusions

Differences in the prevalence of NCDs and preventive interventions can be tracked to aid in the development of effective health equity strategies. Our findings show that the wealthy have a higher prevalence of HTN and DM than the poor section, as well as significant disparities in preventive care among people with HTN or DM. Taken together, the disparities in the prevalence and access to preventive care may be both a cause and a result of socioeconomic disparities. According to the study, the most important socioeconomic variables to track inequality for availing the NCDs preventive care in India are economic level, education, employment, and status of residence. These findings have policy implications in terms of reducing economic disparities in HTN prevalence, for as by giving more labor opportunities to economically disadvantaged groups. Preventive care for NCDs should be considered an essential component of top-down and bottom-up public health policies. Advancement of NCD prevention strategies should be part of the broader public policy framework that includes the participation of both the public and private sectors. This will create a beneficial environment for all socioeconomic groups by improving the healthcare system fairly. Future research may investigate the causal relationships between the socioeconomic determinants of NCD and their inequality.

Author Contributions

All authors (P.M., B.K., L.P., K.B.P., J.K. and B.K.P.) contributed to the concept and study design. P.M. contributed to the conceptualization and study design and acquisition of the study data. B.K. analyzed the study data. P.M. contributed to extensive literature review and writing of the manuscript. All authors contributed to finalizing the manuscript, and subsequent revisions. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable as the data are easily accessible in the public domain and the organization that conducted the field survey for data collection obtained the respondent’s prior consent. The local ethics council of the International Institute for Population Sciences (IIPS) in Mumbai stated that no formal ethics permission was required to carry out research using this data source.

Data Availability Statement

The datasets generated and/or analyzed during this work are available in the repository of the International Institute for Population Sciences in Mumbai, India, and can be viewed freely in the public domain via http://iipsindia.org, accessed on 12 March 2021.

Conflicts of Interest

The authors declare no conflict of interest.

Abbreviations

NCDNon-communicable diseases
GBD Global burden of diseases
HTNHypertension
DMDiabetes mellitus
SCScheduled caste
STScheduled tribes
OBCOther backward class
MPCEMonthly per capita consumption expenditure
RIIRelative index of inequality
CEconomic-related concentration index
SESSocioeconomic status
CIConfidence interval

References

  1. Wang, H.; Abbas, K.M.; Abbasifard, M.; Abbasi-Kangevari, M.; Abbastabar, H.; Abd-Allah, F.; Abdelalim, A.; Abolhassani, H.; Abreu, L.G.; Abrigo, M.R.M.; et al. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: A comprehensive demographic analysis for the Global Burden of Disease Study 2019. Lancet 2020, 396, 1160–1203. [Google Scholar] [CrossRef] [PubMed]
  2. Key_findings_wpp_2015.Pdf. Available online: https://population.un.org/wpp/publications/files/key_findings_wpp_2015.pdf (accessed on 12 March 2021).
  3. World Health Organization. World Report on Ageing and Health; World Health Organization: Geneva, Switzerland, 2015. [Google Scholar]
  4. Marmot, M.; Friel, S.; Bell, R.; Houweling, T.A.; Taylor, S.; on behalf of the Commission on Social Determinants of Health. Closing the gap in a generation: Health equity through action on the social determinants of health. Lancet 2008, 372, 1661–1669. [Google Scholar] [CrossRef] [PubMed]
  5. Balarajan, Y.; Selvaraj, S.; Subramanian, S. Healthcare and equity in India. Lancet 2011, 377, 505–515. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Konings, P.; Harper, S.; Lynch, J.; Hosseinpoor, A.R.; Berkvens, D.; Lorant, V.; Geckova, A.M.; Speybroeck, N. Analysis of socioeconomic health inequalities using the concentration index. Int. J. Public Health 2009, 55, 71–74. [Google Scholar] [CrossRef] [PubMed]
  7. Trends in the Black-White Life Expectancy Gap, 2003–200|Cerebrovascular Disease|JAMA|JAMA Network. Available online: https://jamanetwork.com/journals/jama/fullarticle/1172038 (accessed on 3 February 2022).
  8. Tobias, M.; Blakely, T.; Matheson, D.; Rasanathan, K.; Atkinson, J. Changing trends in indigenous inequalities in mortality: Lessons from New Zealand. Int. J. Epidemiol. 2009, 38, 1711–1722. [Google Scholar] [CrossRef] [PubMed]
  9. Naghavi, M.; Abajobir, A.A.; Abbafati, C.; Abbas, K.M.; Abd-Allah, F.; Abera, S.F.; Aboyans, V.; Adetokunboh, O.; Afshin, A.; Agrawal, A.; et al. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017, 390, 1151–1210. [Google Scholar] [CrossRef] [Green Version]
  10. Arokiasamy, P. India’s escalating burden of non-communicable diseases. Lancet Glob. Health 2018, 6, e1262–e1263. [Google Scholar] [CrossRef] [Green Version]
  11. Noncommunicable Diseases|National Health Portal. Available online: https://www.nhp.gov.in/healthilyliving/ncd2019 (accessed on 3 February 2022).
  12. The Changing Patterns of Cardiovascular Disease and Their Risk Factors in the States of India: The Global Burden of Disease Study 1990–2016—The Lancet Global Health. Available online: https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(18)30407-8/fulltext (accessed on 3 February 2022).
  13. India State-Level Disease Burden Initiative Diabetes Collaborators. The increasing burden of diabetes and variations among the states of India: The Global Burden of Disease Study 1990–2016. Lancet Glob. Health 2018, 6, e1352–e1362. [Google Scholar] [CrossRef] [Green Version]
  14. NCDs POLICY BRIEF–INDIA; February 2011, The World Bank, South Asia Human Development, Health Nutrition, and Population. Available online: https://documents1.worldbank.org/curated/en/281961505994118415/pdf/119405-BRI-P114171-PUBLIC-NCD-IN.pdf (accessed on 12 March 2021).
  15. Engelgau, M.M.; Karan, A.; Mahal, A. The Economic impact of Non-communicable Diseases on households in India. Glob. Health 2012, 8, 9. [Google Scholar] [CrossRef] [Green Version]
  16. Mondal, S.; Van Belle, S. India’s NCD strategy in the SDG era: Are there early signs of a paradigm shift? Glob. Health 2018, 14, 1–9. [Google Scholar] [CrossRef]
  17. Ataguba, J.E.; Akazili, J.; McIntyre, D. Socioeconomic-related health inequality in South Africa: Evidence from General Household Surveys. Int. J. Equity Health 2011, 10, 48. [Google Scholar] [CrossRef] [Green Version]
  18. Glover, J.D.; Hetzel, D.M.; Tennant, S.K. The socioeconomic gradient and chronic illness and associated risk factors in Australia. Aust. N. Z. Health Policy 2004, 1, 8. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  19. Dalstra, A.A.J.; Kunst, E.A.; Borrell, C.; Breeze, E.; Cambois, E.; Costa, G.; Geurts, J.J.M.; Lahelma, E.; Van Oyen, H.; Rasmussen, N.K.; et al. Socioeconomic differences in the prevalence of common chronic diseases: An overview of eight European countries. Leuk. Res. 2005, 34, 316–326. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  20. Di Cesare, M.; Khang, Y.-H.; Asaria, P.; Blakely, T.; Cowan, M.J.; Farzadfar, F.; Guerrero, R.; Ikeda, N.; Kyobutungi, C.; Msyamboza, K.P.; et al. Inequalities in non-communicable diseases and effective responses. Lancet 2013, 381, 585–597. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  21. Corsi, D.J.; Subramanian, S.V. Association between socioeconomic status and self-reported diabetes in India: A cross-sectional multilevel analysis. BMJ Open 2012, 2, e000895. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Agarwal, A.; Jindal, D.; Ajay, V.S.; Kondal, D.; Mandal, S.; Ghosh, S.; Ali, M.; Singh, K.; Huffman, M.D.; Tandon, N.; et al. Association between socioeconomic position and cardiovascular disease risk factors in rural north India: The Solan Surveillance Study. PLoS ONE 2019, 14, e0217834. [Google Scholar] [CrossRef] [Green Version]
  23. Corsi, D.J.; Subramanian, S.V. Socioeconomic Gradients and Distribution of Diabetes, Hypertension, and Obesity in India. JAMA Netw. Open 2019, 2, e190411. [Google Scholar] [CrossRef] [Green Version]
  24. Geldsetzer, P.; Manne-Goehler, J.; Theilmann, M.; Davies, J.I.; Awasthi, A.; Vollmer, S.; Jaacks, L.M.; Bärnighausen, T.; Atun, R. Diabetes and Hypertension in India. JAMA Intern. Med. 2018, 178, 363–372. [Google Scholar] [CrossRef]
  25. Yusuf, S.; Islam, S.; Chow, C.K.; Rangarajan, S.; Dagenais, G.; Diaz, R.; Gupta, R.; Kelishadi, R.; Iqbal, R.; Avezum, A.; et al. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): A prospective epidemiological survey. Lancet 2011, 378, 1231–1243. [Google Scholar] [CrossRef] [Green Version]
  26. McWilliams, J.M.; Meara, E.; Zaslavsky, A.M.; Ayanian, J.Z. Differences in Controlof Cardiovascular Disease and Diabetes by Race, Ethnicity, and Education: U.S. Trends from 1999 to 2006 and Effects of Medicare Coverage. Ann. Intern. Med. 2009, 150, 505–515. [Google Scholar] [CrossRef]
  27. Su, R.; Cai, L.; Cui, W.; He, J.; You, D.; Golden, A. Multilevel Analysis of Socioeconomic Determinants on Diabetes Prevalence, Awareness, Treatment and Self-Management in Ethnic Minorities of Yunnan Province, China. Int. J. Environ. Res. Public Health 2016, 13, 751. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  28. Brown, A.F.; Ettner, S.L.; Piette, J.; Weinberger, M.; Gregg, E.; Shapiro, M.F.; Karter, A.J.; Safford, M.; Waitzfelder, B.; Prata, P.A.; et al. Socioeconomic Position and Health among Persons with Diabetes Mellitus: A Conceptual Framework and Review of the Literature. Epidemiologic Rev. 2004, 26, 63–77. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  29. Budreviciute, A.; Damiati, S.; Sabir, D.K.; Onder, K.; Schuller-Goetzburg, P.; Plakys, G.; Katileviciute, A.; Khoja, S.; Kodzius, R. Management and Prevention Strategies for Non-communicable Diseases (NCDs) and Their Risk Factors. Front. Public Health 2020, 8, 574111. [Google Scholar] [CrossRef] [PubMed]
  30. Arora, M.; Chauhan, K.; John, S.; Mukhopadhyay, A. Multi-Sectoral Action for Addressing Social Determinants of Noncommunicable Diseases and Mainstreaming Health Promotion in National Health Programmes in India. Indian J. Community Med. 2011, 36 (Suppl. S1), 43–49. [Google Scholar] [CrossRef]
  31. GBD 2015 SDG Collaborators. Measuring the health-related Sustainable Development Goals in 188 countries: A baseline analysis from the Global Burden of Disease Study 2015. Lancet 2016, 388, 1813–1850. [Google Scholar] [CrossRef] [Green Version]
  32. Lasi_india_report_2020.Pdf. Available online: https://lasi-india.org/public/documentation/LASI_India_Report_2020.pdf (accessed on 4 February 2022).
  33. Longitudinal Ageing Study in India (LASI)|International Institute for Population Sciences (IIPS). Available online: https://www.iipsindia.ac.in/lasi (accessed on 4 February 2022).
  34. Shrivastava, U.; Misra, A.; Mohan, V.; Unnikrishnan, R.; Bachani, D. Obesity, Diabetes and Cardiovascular Diseases in India: Public Health Challenges. Curr. Diabetes Rev. 2016, 13, 65–80. [Google Scholar] [CrossRef]
  35. Lall, D.; Engel, N.; Devadasan, N.; Horstman, K.; Criel, B. Challenges in primary care for diabetes and hypertension: An observational study of the Kolar district in rural India. BMC Health Serv. Res. 2019, 19, 44. [Google Scholar] [CrossRef] [Green Version]
  36. Wang, H.; Zhang, L.; Hsiao, W. Ill health and its potential influence on household consumptions in rural China. Health Policy 2006, 78, 167–177. [Google Scholar] [CrossRef]
  37. Sergeant, J.C. Relative index of inequality: Definition, estimation, and inference. Biostatistics 2005, 7, 213–224. [Google Scholar] [CrossRef] [Green Version]
  38. Costa-Font, J.; Hernández-Quevedo, C. Measuring inequalities in health: What do we know? What do we need to know? Health Policy 2012, 106, 195–206. [Google Scholar] [CrossRef]
  39. Hosseinpoor, A.R.; Bergen, N.; Kunst, A.; Harper, S.; Guthold, R.; Rekve, D.; D’Espaignet, E.T.; Naidoo, N.; Chatterji, S. Socioeconomic inequalities in risk factors for non communicable diseases in low-income and middle-income countries: Results from the World Health Survey. BMC Public Health 2012, 12, 912. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  40. On Decomposing the Causes of Health Sector Inequalities with an Application to Malnutrition Inequalitiesin Vietnam. Available online: https://openknowledge.worldbank.org/handle/10986/19426 (accessed on 4 February 2022).
  41. O’Donnell, O.; Van Doorslaer, E.; Wagstaff, A.; Lindelow, M. Analyzing Health Equity Using Household Survey Data, October 2007. Available online: https://elibrary.worldbank.org/doi/epdf/10.1596/978-0-8213-6933-3 (accessed on 4 February 2022).
  42. Xu, K. Analysing health equity using household survey data: A guide to techniques and their implementation. Bull. World Health Organ. 2008, 86, 816. [Google Scholar] [CrossRef]
  43. Ramachandran, A.; Snehalatha, C.; Kapur, A.; Vijay, V.; Mohan, V.; Das, A.K.; Rao, P.V.; Yajnik, C.S.; Kumar, K.M.P.; Nair, J.D. High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia 2001, 44, 1094–1101. [Google Scholar] [CrossRef] [PubMed]
  44. Zhu, S.; Hu, J.; McCoy, T.P.; Li, G.; Zhu, J.; Lei, M.; Yuan, J.; Peng, J.; Kong, L. Socioeconomic Status and the Prevalence of Type 2 Diabetes Among Adults in Northwest China. Diabetes Educ. 2015, 41, 599–608. [Google Scholar] [CrossRef]
  45. Vellakkal, S.; Millett, C.; Basu, S.; Khan, Z.; Aitsi-Selmi, A.; Stuckler, D.; Ebrahim, S. Are estimates of socioeconomic inequalities in chronic disease artefactually narrowed by self-reported measures of prevalence in low-income and middle-income countries? Findings from the WHO-SAGE survey. J. Epidemiol. Community Health 2014, 69, 218–225. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Meng, X.-J.; Dong, G.-H.; Wang, D.; Liu, M.-M.; Lin, Q.; Tian, S.; Xu, L.-X.; Hou, H.; Ren, Y.-F.; Lee, Y.L. Prevalence, awareness, treatment, control, and risk factors associated with hypertension in urban adults from 33 communities of China: The CHPSNE study. J. Hypertens. 2011, 29, 1303–1310. [Google Scholar] [CrossRef]
  47. Fu, C.; Chen, Y.; Wang, F.; Wang, X.; Song, J.; Jiang, Q. High prevalence of hyperglycaemia and the impact of high household income in transforming Rural China. BMC Public Health 2011, 11, 862. [Google Scholar] [CrossRef] [Green Version]
  48. Vellakkal, S.; Subramanian, S.V.; Millett, C.; Basu, S.; Stuckler, D.; Ebrahim, S. Socioeconomic Inequalities in Non-Communicable Diseases Prevalence in India: Disparities between Self-Reported Diagnoses and Standardized Measures. PLoS ONE 2013, 8, e68219. [Google Scholar] [CrossRef]
  49. Singh, P.K.; Singh, L.; Dubey, R.; Singh, S.; Mehrotra, R. Socioeconomic determinants of chronic health diseases among older Indian adults: A nationally representative cross-sectional multilevel study. BMJ Open 2019, 9, e028426. [Google Scholar] [CrossRef] [Green Version]
  50. Robbins, J.M.; Vaccarino, V.; Zhang, H.; Kasl, S.V. Socioeconomic status and diagnosed diabetes incidence. Diabetes Res. Clin. Pract. 2005, 68, 230–236. [Google Scholar] [CrossRef]
  51. Kaplan, M.S.; Huguet, N.; Feeny, D.H.; McFarland, B.H. Self-reported hypertension prevalence and income among older adults in Canada and the United States. Soc. Sci. Med. 2010, 70, 844–849. [Google Scholar] [CrossRef] [PubMed]
  52. Korda, R.J.; Paige, E.; Yiengprugsawan, V.; Latz, I.; Friel, S. Income-related inequalities in chronic conditions, physical functioning and psychological distress among older people in Australia: Cross-sectional findings from the 45 and up study. BMC Public Health 2014, 14, 741. [Google Scholar] [CrossRef] [PubMed]
  53. Stringhini, S.; Viswanathan, B.; Gédéon, J.; Paccaud, F.; Bovet, P. The social transition of risk factors for cardiovascular disease in the African region: Evidence from three cross-sectional surveys in the Seychelles. Int. J. Cardiol. 2012, 168, 1201–1206. [Google Scholar] [CrossRef] [PubMed]
  54. Wells, J.C.K.; Pomeroy, E.; Walimbe, S.R.; Popkin, B.M.; Yajnik, C.S. The Elevated Susceptibility to DiabetesinIndia: An Evolutionary Perspective. Front. Public Health 2016, 4, 45. [Google Scholar] [CrossRef] [Green Version]
  55. Prabhakaran, D.; Singh, K.; Roth, G.A.; Banerjee, A.; Pagidipati, N.J.; Huffman, M.D. Cardiovascular Diseases in India Compared With the United States. J. Am. Coll. Cardiol. 2018, 72, 79–95. [Google Scholar] [CrossRef]
  56. Lin, X.; Xu, Y.; Pan, X.; Xu, J.; Ding, Y.; Sun, X.; Song, X.; Ren, Y.; Shan, P.F. Global, regional, and national burden and trend of diabetes in 195 countries and territories: An analysis from 1990 to 2025. Sci. Rep. 2020, 10, 14790. [Google Scholar] [CrossRef]
  57. Khan, J.A.; Trujillo, A.J.; Ahmed, S.; Siddiquee, A.T.; Alam, N.; Mirelman, A.J.; Koehlmoos, T.P.; Niessen, L.W.; Peters, D.H. Distribution of chronic disease mortality and deterioration in household socioeconomic status in rural Bangladesh: An analysis over a 24-year period. Int. J. Epidemiol. 2015, 44, 1917–1926. [Google Scholar] [CrossRef] [Green Version]
  58. Carrieri, V.; Wuebker, A. Assessing inequalities in preventive care use in Europe. Health Policy 2013, 113, 247–257. [Google Scholar] [CrossRef] [Green Version]
  59. Rundall, T.G.; Wheeler, J.R.C. The Effect of Income on Use of Preventive Care: An Evaluation of Alternative Explanations. J. Health Soc. Behav. 1979, 20, 397. [Google Scholar] [CrossRef]
  60. Chentli, F.; Azzoug, S.; Mahgoun, S. Diabetes mellitus in elderly. Indian J. Endocrinol. Metab. 2015, 19, 744–752. [Google Scholar] [CrossRef]
  61. Gatimu, S.M.; John, T.W. Socioeconomic inequalities in hypertension in Kenya: A decomposition analysis of 2015 Kenya STEPwise survey on non-communicable diseases risk factors. Int. J. Equity Health 2020, 19, 1–11. [Google Scholar] [CrossRef] [PubMed]
  62. Neufcourt, L.; Zins, M.; Berkman, L.F.; Grimaud, O. Socioeconomic disparities and risk of hypertension among older Americans: The Health and Retirement Study. J. Hypertens. 2021, 39, 2497–2505. [Google Scholar] [CrossRef] [PubMed]
  63. Thrift, A.G.; Ragavan, R.S.; Riddell, M.A.; Joshi, R.; Thankappan, K.R.; Chow, C.; Oldenburg, B.; Mahal, A.S.; Kalyanram, K.; Kartik, K.; et al. Hypertension in Rural India: The Contribution of Socioeconomic Position. J. Am. Heart Assoc. 2020, 9, e014486. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Schematic figure explaining sample extraction from LASI (2017–2018).
Figure 1. Schematic figure explaining sample extraction from LASI (2017–2018).
Geriatrics 07 00137 g001
Figure 2. Simplified direct acyclic graph exhibiting the hypothesized causal association between economic status and self-reported HTN/DM and its preventative treatment.
Figure 2. Simplified direct acyclic graph exhibiting the hypothesized causal association between economic status and self-reported HTN/DM and its preventative treatment.
Geriatrics 07 00137 g002
Figure 3. Concentration curve for the cumulative proportion of the presence of hypertension and the use of hypertension medications, against the cumulative percentage of wealth, India (LASI). (a) Description of the cumulative proportion of presence of hypertension in the first panel; (b) description of the use of the cumulative percentage of hypertension medications in the second panel.
Figure 3. Concentration curve for the cumulative proportion of the presence of hypertension and the use of hypertension medications, against the cumulative percentage of wealth, India (LASI). (a) Description of the cumulative proportion of presence of hypertension in the first panel; (b) description of the use of the cumulative percentage of hypertension medications in the second panel.
Geriatrics 07 00137 g003
Figure 4. Concentration curve for the cumulative proportion of the presence of diabetes and the use of diabetes medicines, versus the cumulative percent of wealth, India (LASI). (a) Description of the cumulative proportion of presence of diabetes in the first panel; (b) Description of the cumulative proportion of presence of diabetes medicine use in the second panel.
Figure 4. Concentration curve for the cumulative proportion of the presence of diabetes and the use of diabetes medicines, versus the cumulative percent of wealth, India (LASI). (a) Description of the cumulative proportion of presence of diabetes in the first panel; (b) Description of the cumulative proportion of presence of diabetes medicine use in the second panel.
Geriatrics 07 00137 g004
Table 1. Distribution of NCD and its prevention (treatment-seeking) among the respondents aged 60 years and above.
Table 1. Distribution of NCD and its prevention (treatment-seeking) among the respondents aged 60 years and above.
Characteristics Profile of the Respondents Aged 60 and above Population (n = 31,464)
VariablesnProportionCI
HTN and its preventive care
HTN10,9950.33[0.32–0.34]
Currently on medication85070.77 a[0.76–0.79]
Diabetics and its preventive care
DM48600.14[0.13–0.15]
Currently on medicine40220.82 b[0.79–0.84]
Demographic variables
Age group
60–6918,9740.59[0.57–0.60]
70–7991010.3[0.29–0.31]
80 and above33890.11[0.11–0.12]
Place of residence
Rural20,7250.71[0.69–0.72]
Urban10,7390.29[0.28–0.31]
Gender
Male15,0980.47[0.46–0.49]
Female15,3660.53[0.51–0.54]
Cast group
Schedule caste51400.19[0.19–0.20]
Schedule tribe51730.08[0.08–0.09]
Other backward class (OBC)11,8860.46[0.45–0.48]
Others82180.26[0.25–0.27]
Economic status
Poorest64840.22[0.21–0.23]
Poorer64770.22[0.21–0.23]
Middle64160.21[0.20–0.22]
Richer61700.19[0.18–0.20]
Richest59170.16[0.15–0.17]
Education level
Illiterate16,8890.57[0.55–0.58]
Primary or below75600.23[0.22–0.23]
Secondary55600.17[0.16–0.18]
college and above14550.04[0.04–0.05]
Marital status
Married19,9200.62[0.60–0.63]
Single11,5440.38[0.37–0.40]
Religion
Hindu23,0370.82[0.81–0.83]
Muslim37310.11[0.10–0.12]
Christian31500.03[0.03–0.03]
Other15460.04[0.03–0.04]
Employment status
Unemployed93070.42[0.41–0.43]
Employed13,3730.58[0.57–0.59]
Note: (1) Numbers: unweighted, proportion: weighted; (2) a preventive care proportions among individuals with HTN; (3) b preventive care proportions among individuals with DM.
Table 2. Showsthe proportion of NCDs and preventive care (medicine use) by economic quintile, as well as economic inequality (%).
Table 2. Showsthe proportion of NCDs and preventive care (medicine use) by economic quintile, as well as economic inequality (%).
HTN and Its Preventive CareDiabetes Mellitus and Its Preventive Care
Presence of HTNCurrently on MedicationPresence of DMCurrently on Medication
Respondents (n)31,46410,99531,4644860
Poorest, % (95%CI) a5.66 [5.20–6.21]12.01 [10.72–13.43]2.16 [1.89–2.46]11.47 [9.43–13.89]
Poorer, % (95%CI) a6.26 [5.81–6.74]14.37 [12.94–15.92]2.25 [2.0–2.52]12.35 [10.33–14.71]
Middle, % (95%CI) a6.52 [5.97–7.12]15.07 [13.87–16.36]2.61 [2.30–2.95]13.92 [11.72–16.47]
Richer, % (95%CI) a7.28 [6.47–8.18]18.09 [16.27–20.05]3.51 [2.80–4.39]21.32 [18.15–24.88]
Richest, % (95%CI) a7.06 [6.27–7.95]17.87 [16.03–19.87]3.73 [2.97–4.66]22.54 [19.10–26.40]
RII b, (95%CI)0.29 *** [0.28–0.30]0.75 *** [0.73–0.76]0.16 *** [0.15–0.17]0.81 *** [0.79–0.83]
RII c, (95%CI)0.18 *** [0.17–0.20]0.56 *** [0.53–0.60]0.06 *** [0.05–0.07]0.69 *** [0.64–0.76]
C, (95%CI)0.13 *** [0.09–0.16]0.10 *** [0.07–0.13]0.10 *** [0.06–0.14]0.09 *** [0.04–0.15]
Note: (1) 95% CI: 95% confidence interval, “C”: concentration index, “RII”: relative index of inequality; (2) a shows weighted unadjusted prevalence estimates; (3) b the RII values were established using Poisson regressions with robust variance and adjusted for gender and age; (4) c: RII values established by Poisson regressions and adjusted for all other explanatory variables; (5) *** p < 0.001.
Table 3. Decomposition of the concentration index of chronic diseases and preventive care.
Table 3. Decomposition of the concentration index of chronic diseases and preventive care.
HTN and Its Preventive CareDiabetes Mellitus and Its Preventive Care
Presence of HTNCurrently on MedicationPresence of DMCurrently on Medication
dy/dxCon.%con.dy/dxCon.%con.dy/dxCon.%con.dy/dxCon.%con.
Age Group (Ref: 60–69 years)
70–790.018 *<0.0010.0560.015<0.0010.06−0.004<0.001−0.015−0.001<0.001−0.005
80 and above0.002<0.001−0.0060.018<0.001−0.098−0.031 ***<0.0010.168−0.083 **<0.0010.48
Place of residence (Ref: rural)
Urban0.098 ***<0.0010.6360.132 ***0.0011.0910.086 ***<0.0010.7260.076 ***<0.0010.675
Gender (Ref: female)
Male−0.086 ***−0.005−3.553−0.042 **−0.002−1.99−0.001<0.001−0.03−0.062 **−0.003−3.211
Cast Group (Ref: schedule caste)
Schedule tribe−0.080 ***0.0021.303−0.025<0.0010.527−0.032 **<0.0010.681−0.017<0.0010.373
Other backwardclass (OBC)0.009<0.0010.0990.047 ***<0.0010.6710.016 **<0.0010.2390<0.0010.005
None of them0.023 *0.0032.5710.051 **0.0077.3040.0120.0021.810.0150.0022.381
Economic Status (Ref: poorest)
Poorer0.035 ***−0.009−7.0890.065 ***−0.017−16.710.013−0.003−3.4440.02−0.005−5.44
Middle0.054 ***0.0032.2680.072 ***0.0043.8180.027 ***0.0011.4710.012<0.0010.065
Richer0.083 ***0.02317.7870.108 ***0.0329.690.055 ***0.01515.410.115 ***0.03233.969
Richest0.104 ***0.03728.610.143 ***0.05250.170.072 ***0.02625.850.107 ***0.03940.64
Education Level (Ref: illiterate)
Primary or below0.095 ***0.0021.6270.054 ***0.0011.1750.068 ***0.0011.520.057 **0.0011.35
Secondary0.128 ***0.0097.4430.066 ***0.0054.8730.092 ***0.0076.9170.050 *0.0043.994
college and above0.133 ***0.0010.9520.094 ***0.0010.8560.088 ***<0.0010.816−0.036<0.001−0.354
Marital Status (Ref: single)
Married−0.002<0.001−0.2250.0160.0022.0460.015 **0.0022.0330.055 **0.0077.839
Religion (Ref: Hindu)
Muslim0.027 *<0.001−0.1−0.018<0.0010.086−0.014<0.0010.0660.041<0.001−0.209
Christian0.082 ***<0.001−0.010.101 ***<0.001−0.0160.073 ***<0.001−0.0120.05<0.001−0.009
Other0.056 ***<0.0010.170.025<0.0010.0970.015<0.0010.0610.024<0.0010.099
Employment Status (Ref: unemployment)
Employed−0.108 ***0.0032.45−0.090 ***0.0032.611−0.060 ***0.0021.78−0.076 ***0.0022.374
p * < 0.5, p ** < 0.01, *** p < 0.001.
Table 4. Description of factor contributions and age-sex-adjusted Cs.
Table 4. Description of factor contributions and age-sex-adjusted Cs.
HTN and Its Preventive CareDiabetes Mellitus and Its Preventive Care
Presence of HTNCurrently on MedicationPresence of DMCurrently on Medication
Age-sex groups, Con. (% con.)−0.005 (−3.503%)−0.002 (−2.028%)<0.001 (0.123%)−0.003 (−2.736%)
Economic status, Con. (% con.)0.054 (41.576%)0.069 (66.968%)0.039 (39.287%)0.066 (68.938%)
Other factors, Con. (% con.)0.02 (16.916%)0.02 (21.321%)0.014 (16.637%)0.016 (18.518%)
Residual, Con. (% con.)0.061 (45.001)0.013 (13.739%)0.047 (43.953%)0.011 (15.280%)
C0.130.100.100.09
Age-sex adjusted C0.1350.1020.100.093
Note: Con.: the absolute contribution of the determinants to the concentration index; % con.:the percentage contribution of determinants to the total concentration index; C: concentration index.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Khura, B.; Mohanty, P.; Patnaik, L.; Pradhan, K.B.; Khubchandani, J.; Padhi, B.K. Socioeconomic Inequalities in the Prevalence of Non-Communicable Diseases among Older Adults in India. Geriatrics 2022, 7, 137. https://doi.org/10.3390/geriatrics7060137

AMA Style

Khura B, Mohanty P, Patnaik L, Pradhan KB, Khubchandani J, Padhi BK. Socioeconomic Inequalities in the Prevalence of Non-Communicable Diseases among Older Adults in India. Geriatrics. 2022; 7(6):137. https://doi.org/10.3390/geriatrics7060137

Chicago/Turabian Style

Khura, Bikash, Parimala Mohanty, Lipilekha Patnaik, Keerti Bhusan Pradhan, Jagdish Khubchandani, and Bijaya Kumar Padhi. 2022. "Socioeconomic Inequalities in the Prevalence of Non-Communicable Diseases among Older Adults in India" Geriatrics 7, no. 6: 137. https://doi.org/10.3390/geriatrics7060137

Article Metrics

Back to TopTop